Bibliografia UJ CM

1/5
Fredrik Schjesvold, Paul G. Richardson, Thierry Facon, Adrian Alegre, Andrew Spencer, Artur Jurczyszyn, Kazutaka Sunami, Laurent Frenzel, Chang-Ki Min, Sophie Guillonneau, Peggy L. Lin, Solenn Le-Guennec, Frank Campana, Helgi van de Velde, Samira Bensfia, Sara Bringhen.
Errata corrige : Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis.
Haematologica
2022 : Vol. 107, nr 3, s. 774-775
Autor korespondencyjny: Sara Bringhen.
Open Access Creative Commons Attribution License CC-BY-NC 4.0.
p-ISSN: 0390-6078
KOR
Adres url:
2/5
Fredrik H. Schjesvold, Paul G. Richardson, Thierry Facon, Adrián Alegre, Andrew Spencer, Artur Jurczyszyn, Kazutaka Sunami, Laurent Frenzel, Chang-Ki Min, Sophie Guillonneau, Peggy L. Lin, Solenn Le-Guennec, Frank Campana, Helgi van de Velde, Samira Bensfia, Sara Bringhen.
Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma : ICARIA-MM subgroup analysis.
Haematologica
2021 : Vol. 106, nr 4, s. 1182-1187, il., bibliogr. 5 poz.
Autor korespondencyjny: Sara Bringhen.
p-ISSN: 0390-6078
AZ
ORG
AIF
IF: 11.049
Adres url:
Streszczenie w PubMed:
3/5
Ajay K. Gopal, Stephen J. Schuster, Nathan H. Fowler, Judith Trotman, Georg Hess, Jing-Zhou Hou, Abdulraheem Yacoub, Michael Lill, Peter Martin, Umberto Vitolo, Andrew Spencer, John Radford, Wojciech Jurczak, James Morton, Dolores Caballero, Sanjay Deshpande, Gary J. Gartenberg, Shean-sheng Wang, Rajendra N. Damle, Michael Schaffer, Sriram Balasubramanian, Jessica Vermeulen, Bruce D. Cheson, Gilles Salles.
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.
Journal of Clinical Oncology
2018 : Vol. 36, nr 23, s. 2405-2412
Autor korespondencyjny: Ajay K. Gopal.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 28.245
Adres url:
Streszczenie w PubMed:
DOI:
4/5
Meletios A. Dimopoulos, Philippe Moreau, Antonio Palumbo, Douglas Joshua, Ludek Pour, Roman Hajek, Thierry Facon, Heinz Ludwig, Albert Oriol, Hartmut Goldschmidt, Laura Rosinol, Jan Straub, Aleksandr Suvorov, Carla Araujo, Elena Rimashevskaya, Tomas Pika, Gianluca Gaidano, Katja Weisel, Vesselina Goranova-Marinova, Anthony Schwarer, Leonard Minuk, Tamas Masszi, Ievgenii Karamanesht, Massimo Offidani, Vania Hungria, Andrew Spencer, Robert Z. Orlowski, Heidi H. Gillenwater, Nehal Mohamed, Shibao Feng, Wee-Joo Chng, ENDEAVOR investigators.
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Lancet. Oncology
2016 : Vol. 17, nr1, s. 27-38, il., bibliogr. 23 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 33.900
Adres url:
Streszczenie w PubMed:
5/5
Evangelos Terpos, Gareth Morgan, Meletios A. Dimopoulos, Matthew T. Drake, Suzanne Lentzsch, Noopur Raje, Orhan Sezer, Ramon Garcia-Sanz, Kazuyuki Shimizu, Ingemar Turesson, Tony Reiman, Artur Jurczyszyn, Giampaolo Merlini, Andrew Spencer, Xavier Leleu, Michele Cavo, Nikhil Munshi, S. Vincent Rajkumar, Brian G.M. Durie, G. David Roodman.
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.
Journal of Clinical Oncology
2013 : Vol. 31, nr 18, s. 2347-2357, bibliogr. 90 poz., abstr.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 17.960
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ